149 related articles for article (PubMed ID: 7669646)
1. The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11-year period.
Mourellou O; Chaidemenos GC; Koussidou T; Kapetis E
Br J Dermatol; 1995 Jul; 133(1):83-7. PubMed ID: 7669646
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
[TBL] [Abstract][Full Text] [Related]
3. High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study.
Chaidemenos G; Apalla Z; Koussidou T; Papagarifallou I; Ioannides D
J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):206-10. PubMed ID: 20569289
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975.
Lever WF; Schaumburg-Lever G
Arch Dermatol; 1977 Sep; 113(9):1236-41. PubMed ID: 900969
[TBL] [Abstract][Full Text] [Related]
5. An alternate-day corticosteroid regimen for pemphigus vulgaris. A 13-year prospective study.
Chaidemenos GCh; Mourellou O; Koussidou T; Tsatsou F
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1386-91. PubMed ID: 17958846
[TBL] [Abstract][Full Text] [Related]
6. Treatment of pemphigus vulgaris and pemphigus foliaceus: experience with 71 patients over a 20 year period.
Fernandes NC; Perez M
Rev Inst Med Trop Sao Paulo; 2001; 43(1):33-6. PubMed ID: 11246281
[TBL] [Abstract][Full Text] [Related]
7. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
Werth VP
Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
[TBL] [Abstract][Full Text] [Related]
8. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Luger TA
Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Pemphigus Vulgaris and Foliaceus with Adjuvant Rituximab Compared to Immunosuppression Alone: Real-Life Experience.
Snast I; Spitzer L; Hodak E; Levi A; Mimouni D; Leshem YA
Dermatology; 2021; 237(2):179-184. PubMed ID: 32756069
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)].
Benoit Corven C; Carvalho P; Prost C; Verret JL; Saiag P; Noblesse I; Bedane C; Chosidow O; Young P; Roujeau JC; Joly P
Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):13-5. PubMed ID: 12605150
[TBL] [Abstract][Full Text] [Related]
11. Steroid-pulse therapy in pemphigus vulgaris long term follow-up.
Chryssomallis F; Dimitriades A; Chaidemenos GC; Panagiotides D; Karakatsanis G
Int J Dermatol; 1995 Jun; 34(6):438-42. PubMed ID: 7657447
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of pemphigus. Critical remarks based on 44 clinical cases].
Smolle J
Hautarzt; 1985 Feb; 36(2):96-102. PubMed ID: 2985524
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of juvenile pemphigus vulgaris with intravenous immunoglobulins].
Szép Z; Danilla T; Buchvald D
Cas Lek Cesk; 2005; 144(10):700-3. PubMed ID: 16279438
[TBL] [Abstract][Full Text] [Related]
14. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
Kim MR; Kim HC; Kim SC
Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
[TBL] [Abstract][Full Text] [Related]
15. Outcome of pemphigus vulgaris.
Kavusi S; Daneshpazhooh M; Farahani F; Abedini R; Lajevardi V; Chams-Davatchi C
J Eur Acad Dermatol Venereol; 2008 May; 22(5):580-4. PubMed ID: 18194237
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris.
Sami N; Qureshi A; Ruocco E; Ahmed AR
Arch Dermatol; 2002 Sep; 138(9):1158-62. PubMed ID: 12224976
[TBL] [Abstract][Full Text] [Related]
17. Enteric-coated mycophenolate sodium in the treatment of refractory pemphigus.
Bongiorno MR; Pistone G; Doukaki S; Aricò M
Int J Dermatol; 2010 Jun; 49(6):693-9. PubMed ID: 20618478
[TBL] [Abstract][Full Text] [Related]
18. The course and prognosis of pemphigus. A review of 115 patients.
Seidenbaum M; David M; Sandbank M
Int J Dermatol; 1988 Oct; 27(8):580-4. PubMed ID: 3209320
[TBL] [Abstract][Full Text] [Related]
19. The impact of stratifying initial dose of corticosteroids by severity of pemphigus vulgaris on long-term disease severity.
Lyakhovitsky A; Baum S; Scope A; Amichai B; Barzilai A; Rimer J; Trau H
Int J Dermatol; 2011 Aug; 50(8):1014-9. PubMed ID: 21781080
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate is effective in the treatment of pemphigus vulgaris.
Enk AH; Knop J
Arch Dermatol; 1999 Jan; 135(1):54-6. PubMed ID: 9923781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]